21249 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21249)
  2. Survivorship Research (5131)
  3. Department of Medicine (4874)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4019)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (582)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (126)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21249)
  2. Survivorship Research (5131)
  3. Department of Medicine (4874)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4019)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (920)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In patients with stage I lung adenocarcinoma, tumor budding is a significant prognostic factor for recurrence, independent of the IASLC/ATS/ERS classification, and correlates with a protumor immune microenvironment
    Meeting Abstract

    Kadota, K.; Yeh, Y. C.; Rizk, N. P.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Reclassification of resected non-small cell lung carcinomas originally diagnosed as squamous cell carcinoma, after reevaluation using immunohistochemical analysis (P40, P63, TTF-1, and napsin A): Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Kadota, K.; Nitadori, J.; Rusch, V. W.; Rekhtman, N.; Sarkaria, I. S.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Tumor budding and nuclear grade, but not histologic subtype, are significant prognostic factors, independent of TNM stage, in patients with lung squamous cell carcinoma
    Meeting Abstract

    Kadota, K.; Nitadori, J.; Finley, D. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • "Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection
    Meeting Abstract

    Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • High local control rates with postoperative radiation therapy in incompletely resected non-small cell lung cancer (NSCLC) patients
    Meeting Abstract

    Din, S. U.; Wu, A. J.; Gelblum, D. Y.; Foster, A.; Chaft, J. E.; Rizk, N. P.; Huang, J.; Rimner, A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of microarray and RNA sequencing platforms for profiling micrornas in formalin-fixed, paraffin-embedded non-small cell lung cancer specimens
    Meeting Abstract

    Buitrago, D.; Kadota, K.; Rusch, V. W.; Patnaik, S. K.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma
    Meeting Abstract

    Bograd, A.; Kadota, K.; Nitadori, J.; Cherkassky, L.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Treatment of liver cysts
    Book Section

    Kingham, T. P.; DeMatteo, R. P.
    In Lillemoe, K. D.; Jarnagin, W. R. (Eds.) Hepatobiliary and Pancreatic Surgery (2013)

    Fulltext@MSK | Save